Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin.

Evid Based Complement Alternat Med · 2014 · PMC4247936 · PMID 25478000

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

showed a trendP = 0.069so close (0.05 < p ≤ 0.1)

Our further data from Protocol II showed a trend toward lowering PCSK9 ( P = 0.069, compared with baseline).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.